Agreement is signed over four biosimilar monoclonal antibody products for cancer and immune disease therapy.
The company hope that the technology will contribute to the development of therapies to help tackle the disease.
Canadian research institute to collaborate with pharmaceutical company.
Canadian and US institutions collaborate to develop tests for diabetes and haemoglobin variants.
Two US-based companies join to create an optimized approach to the measurement of glucose levels in diabetes research.
Transgenomic Inc collaborates with Amgen to develop RAScan™ test.
Recent study shows that cartilage and synovial tissues may contribute to joint damage.
Eckert & Ziegler Vitalea Science introduce complementary products and services of Radiopharma.
Barnett Institute USA celebrates its 40th anniversary with a conference.
New partnership aims to aid the discovery of oncology therapeutics.